OCT 08, 2018 7:52 AM PDT

Nuclear Imaging: The Next Generation of Biopsy

WRITTEN BY: Nicholas Breehl

Organ transplantation is a significant procedure that brings the potential for complication. Often, our immune systems can overact to the new organ and reject the transplantation. The immune system will recognize the organ as a foreign substance that it must eliminate, resulting in a lifetime of rigorous treatment to stave off the negative impacts of the procedure. For reasons such as these, physicians seek to get ahead of the risk by closely monitoring the organ function.

A team of researchers has published their work in the Journal of Nuclear Medicine describing techniques are ultimately be safer for patients. Usually, to determine the functionality of an organ or tissue, physicians will make use of biopsy methods. However, biopsy procedures are invasive and not without potential for complication. Positron-emission tomography or PET imaging methods were explored as an alternative to a biopsy.

PET imaging is described as a scan that will reveal how tissues and organs are functioning. The PET imaging makes use of a radioactive drug (the tracer) to highlight activity. PET imaging can detect disease before it appears on other imaging tests.

Depending on the tissue or organ being observed, tracers are injected, swallowed or inhaled. The tracer will collect in areas of the body that have high levels of chemical activity, which often correspond to regions of disease. The imaging will display on a monitor as bright spots.

In the study performed by researchers at the University of California and University of Pennsylvania, they utilized a molecule called 18 F-FAC as their radioactive tracer to observe liver function. The creation of a mouse model allowed for testing of T cells in the liver. T cells in the liver are looked for in this case because of their role clearing foreign substances from the body. Thus, their presence would indicate the potential for rejection of a transplanted liver.

"The personalized treatment of patients suffering from immune attack on the liver will require precise and quantitative methods for measuring T cells in the liver," said Peter Clark, Ph.D. "Our work describes in a preclinical model one such way of doing this. We envision that if this approach is translated into the clinic, it could lead to fewer liver biopsies and more precise treatment of patients with immune-related liver disease."

The research of molecular imaging performed here might have the potential to be applied in diagnoses of other chronic liver infections.

The data from this study suggest that PET can be used to noninvasively visualize activated T cells and inflamed liver cells in mice with autoimmune hepatitis.

Sources: Journal of Nuclear Medicine, YouTube, Mayo Clinic

About the Author
Master's (MA/MS/Other)
You May Also Like
OCT 27, 2022
Cardiology
Consistent Lack of Sleep Increases Risk of Heart Disease and Inflammatory Disorders
Consistent Lack of Sleep Increases Risk of Heart Disease and Inflammatory Disorders
Chronic sleep deprivation harms immune cells, which may lead to heart problems and inflammation.
NOV 11, 2022
Drug Discovery & Development
The development of a thermostable vaccine for tuberculosis
The development of a thermostable vaccine for tuberculosis
Tuberculosis is the deadliest infectious disease worldwide (prior to, and aside from COVID-19 infections). Acc ...
NOV 14, 2022
Neuroscience
How COVID-19 Can Disrupt the Brain
How COVID-19 Can Disrupt the Brain
The virus that causes COVID-19 does not infect neurons, or if it does, that only happens in rare cases. But COVID-19 can ...
DEC 05, 2022
Drug Discovery & Development
Characterization and Manufacturing of AAVs for Gene Therapy
Characterization and Manufacturing of AAVs for Gene Therapy
The backdrop upon which every successful gene therapy is developed is the ability to safely and specifically target cell ...
DEC 11, 2022
Drug Discovery & Development
Novel Dermatitis Treatment Produces Long-Term Results in Clinical Trials
Novel Dermatitis Treatment Produces Long-Term Results in Clinical Trials
A monoclonal antibody drug known as rocatinlimab produced significant results in patients with moderate to severe atopic ...
JAN 13, 2023
Immunology
B Cell Surface Features Revealed by Advanced Microscopy
B Cell Surface Features Revealed by Advanced Microscopy
With an advanced technique called lattice light sheet microscopy, scientists have revealed structures on the surface of ...
Loading Comments...